Welcome to kongre.net
Speaker
Chief Scientific Officer, Immunokey
John bridgeman, Chief Scientific Officer at Immunokey, is speaking at 15th Tumour Models London Summit 2026 (London, United Kingdom, 2–3 Dec 2026) in the session “Evidence – Using Translational Models to Overcome Tumour Antigen Heterogeneity & Improve CAR-T Responses in Solid Tumours”.
Senior Leader-Head of Translational Pharmacology, Roche
Chief Scientific Officer, Hemispherian
Director, Non-Clinical Projects Operations, Eli Lilly & Co.
Chief Scientific Officer, Lytix Biopharma AS
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by John bridgeman, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].